Taylor Wessing primarily supports transactions in the mid-cap segment and frequently acts across the technology, healthcare and life sciences sectors. Private equity houses and their portfolio companies are regularly advised across locations and practices; cross-border matters are routinely handled with the location in London. The transactional support is complemented by the advice on buy-and-build strategies and management participations. Maria Weiers heads the team since Walter Henle’s retirement in September 2022; Weiers is well versed in buy-outs and exits. Michael Lamsa moved to Gowling WLG in April 2023, where he co-leads the M&A, PE and VC practices.
Legal 500 Editorial commentary
Key clients
- AFINUM
- Alpina Partners
- Balderton Capital
- Borromin Capital Fund IV
- Cordet Capital Partners
- ECM Equity Capital Management
- EQT Infrastructure
- Equistone
- Inflexion
- International Chemical Investors Group
- NordHolding / Zentrum Gesundheit Gruppe
- Oberberg Gruppe
- Pinova
- Protect Medical Holding GmbH
- Sanecum
- Trilantic
Work highlights
- Advising International Chemical Investors SE on the acquisition of the Evonik chemical site in Lülsdorf and the associated cyanuric chloride business in Wesseling, North Rhine-Westphalia, as well as inprotec AG.
- Advising EQT on the sale of a minority stake in Global Connect, provider of fiber-optic data communications and data center services, to Mubadala.
- Advising NORD Holding and Zentrums Gesundheit on the acquisition of the REALEYES Group, a premium provider in the field of ophthalmology.